COMPASS THERAPEUTICS, INC. (CMPX) Return on equity 2023–2025
COMPASS THERAPEUTICS, INC. (CMPX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-33.8%FY2025 · since FY2023: -28.6% → -33.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -33.8% | +5.6 pp |
| FY2024 | -39.4% | -10.8 pp |
| FY2023 | -28.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice